Baxter Healthcare Corporation recalls Clindamycin Phosphate in 0.9% Sodium Chloride Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations
- Products
-
- Clindamycin Phosphate in 0.9% Sodium Chloride Injection
- Where it was sold
-
US Nationwide; Puerto Rico; and Chile.
Nationwide
- Units affected
- N/A
- About this recall
- Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg/mL), 50 mL Single-Dose GALAXY Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-9549-50.